 TGen was established in 2002 by Jeffrey Trent in Phoenix, Arizona, United States.The Institute began with a investment from Arizona public- and private-sector investors.TGen conducts research on a number of human disorders including Alzheimer's disease, Autism, Parkinson's, Diabetes and numerous forms of cancer and a variety of other complex human diseases.